<DOC>
	<DOCNO>NCT01267448</DOCNO>
	<brief_summary>Saxagliptin + Metformin XR ( S+M ) effective stabilize blood glucose ( BG ) level patient newly diagnose type 2 diabetes ( T2DM ) severe hyperglycemia ( BG level 300 450 mg/dl ) glucose toxicity criterion inpatient admission occurrence severe hypoglycemia compare glipizide XL . The study may provide preliminary evidence support role S+M bridging , stabilize safe therapy patient severe hyperglycemia</brief_summary>
	<brief_title>Outpatient Discharge Therapy With Saxagliptin+MetforminXR v GlipizideXL Type 2 Diabetes With Severe Hyperglycemia</brief_title>
	<detailed_description>There little information regard diabetes discharge regimens patient recently diagnose diabetes ( &lt; 1 year duration ) present severe hyperglycemia ( blood glucose 300-450 mg/dl ) ED clinical setting need admit . A combination Saxagliptin+Metformin XR , could potential drug combination test initial treatment circumstance compare Glipizide XL show effective previous study . We expect Saxagliptin improve beta cell function decrease glucagon level show DPP-IV class medication turn improve blood glucose level , Metformin XR may reduce insulin resistance hepatic glucose output . Such discharge therapy may help prevent deterioration acute metabolic complication ( DKA hyperosmolar state ) avoid hospitalization . A high proportion patient may achieve glycemic target without significant hypoglycemia measure self glucose monitor objectively continuous glucose monitoring system ( CGMS ) . Such easy regimen may safely bridge time gap patient see provider .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glipizide</mesh_term>
	<criteria>1 . Target Population 1 . Subjects recently diagnose T2DM ( less 1 year duration ) either drug na√Øve take oral antidiabetic agent insulin 2 week . 2 . FBG RBG &gt; 300mg/dl &lt; 450mg/dl 2 . Age Sex 1 . Men woman age 18 75 year age . 2 . Women childbearing potential ( WOCBP ) must use adequate method contraception avoid pregnancy throughout study 4 week last dose study drug minimize risk pregnancy . WOCBP must negative serum urine pregnancy test ( minimum sensitivity 25 IU/L equivalent unit HCG ) within 72 hour start investigational product . 1 . Sex Reproductive Status 1 . WOCBP unwilling unable use acceptable method avoid pregnancy entire study period 4 week last dose study drug . 2 . Women pregnant breastfeeding . 3 . Women positive pregnancy test . 4 . Sexually active fertile men use effective birth control partner WOCBP . 2 . Target Disease Exceptions 1 . Type 2 diabetes weight less 120 pound 2 . Type 1 diabetes 3 . History diabetic ketoacidosis hyperosmolar nonketotic coma 3 . Medical History Concurrent Diseases 1 . Age &gt; 75 year 2 . History congestive heart failure 3 . Evidence impair sensorium and/or dementia 4 . Current history alcohol substance abuse 5 . Patients acute active chronic medical illness 4 . Physical Laboratory Test Findings 1 . FBG /or RGB &lt; 300 mg/dl &gt; 450 mg/dl 2 . Unstable vitals sign ( temperature &gt; 101 degree Fahrenheit , systolic blood pressure &lt; 90 &gt; 180 mmhg , diastolic blood pressure &lt; 60 &gt; 110 mmhg , heart rate &lt; 60 &gt; 120 beats/minute ) 3 . Electrolyte imbalance ( serum bicarbonate level &lt; 20 mEq/L , serum sodium &lt; 125 &gt; 150 mEq/L , serum potassium &lt; 3.5 &gt; 5.5 mEq/L ) , serum creatinine 1.5 male 1.4 female , creatinine clearance less 60ml/min , liver enzymes 3 time upper limit normal range . 4 . HbA1c &gt; 12 % ( base previous study ( 4 ) patient HbA1c &gt; 12 high rate nonresponders ) 5 . Liver enzymes 3 time upper limit normal range . 6 . Allergies Adverse Drug Reactions Subjects history serious hypersensitivity reaction saxagliptin , glipizide metformin XR . 5 . Prohibited Treatments and/or Therapies ) Treatment systemic cytochrome P450 3A4 ( CYP 3A4 ) inhibitor . 6 . Other Exclusion Criteria 1 . Prisoners subject involuntarily incarcerate . 2 . Subjects compulsorily detain treatment either psychiatric physical ( eg , infectious disease ) illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Diabetes Mellitus Type2 .</keyword>
	<keyword>Severe Hyperglycemia - blood glucose level &gt; 300mg/dl .</keyword>
</DOC>